EUClinicalTrials.govClinical trialNot applicableRecruiting
Evaluation of an MRI-based Prostate Cancer Screening Program (VISIONING): 5-Year Follow-up Round (VISIONING III)
Official record
- Identifier
NCT07762911- Recruiting locations
country
Switzerland- Interventions studied
- MRI
- Lead sponsor
- University Hospital, Basel, Switzerland
- Target enrolment
- 300 participants
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Status
- Recruiting
- First posted
- Aug 13, 2026
- Last updated on the registry
- Aug 13, 2026
- Age
- 50 Years
- Sex
- MALE
- Study contact
- The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.
- Eligibility criteria
Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.
Inclusion Criteria: * "well-informed men" with the wish for prostate cancer screening: * prostate biopsy naïve * life expectancy \> 10 years * Paticipant in the VISIONING study Exclusion Criteria: * prostate volume \> 80ml * acute urinary tract infection UTI * NIH-CPSI score over or equal to19 * IPSS score over or equal to 20 (leads to initiation of urologic diagnostics and treatment) * life expectancy \< 10 years
- Indexed under
- Prostate Cancer